Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
WinVest Acquisition Corp. Announces Closing of $100 Million Initial Public Offering
-
DTx Pharma to Present at Upcoming Investor Conferences
-
IPO for SPAC WinVest Acquisition Corp. (WINV) Opens at $10.07
-
WinVest Acquisition Corp. (WINVU) Prices 10M Unit IPO at $10/unit
-
WinVest Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering
-
WinVest Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering
-
Pacifico Acquisition Corp. (PAFOU) Prices 5M Unit IPO at $10/unit
-
Pacifico Acquisition Corp. Announces Pricing of $50 Million Initial Public Offering
-
Pacifico Acquisition Corp. Announces Pricing of $50 Million Initial Public Offering
-
REGENXBIO to Participate in Upcoming Investor Conferences
-
Abri SPAC I, Inc. Announces the Separate Trading of its Common Stock and Warrants, Commencing September 8, 2021
-
Form 25-NSE Chardan Healthcare Acqui Filed by: NYSE AMERICAN LLC
-
Form 8-K Chardan Healthcare Acqui For: Sep 01
-
Renovacor, Inc. Closes Its Business Combination with Chardan Healthcare Acquisition 2 Corp. and Will Begin Trading on the New York Stock Exchange
-
Metagenomi Announces Participation in Fall Investor Conferences
-
Chardan Healthcare Acquisition 2 Corp (CHAQ) Stockholders Approve Merger with Renovacor, Inc
-
Chardan Healthcare Acquisition 2 Corp. Announces Stockholder Approval Of Business Combination With Renovacor, Inc.
-
CHW Acquisition Corporation Announces Closing of Upsized $125,000,000 Initial Public Offering Including Partial Exercise of Over-Allotment Option
-
Avidity Biosciences to Participate in Upcoming Investor Conferences
-
Mesoblast Limited (MESO) PT Lowered to $6.50 at Chardan Capital Markets
-
Form DEFA14A Chardan Healthcare Acqui
-
IPO for SPAC CHW Acquisition Corporation (CHWA) Opens at $9.88
-
CHW Acquisition Corporation (CHWAU) Prices Upsized 11M Unit Offering at $10/unit
-
CHW Acquisition Corporation Announces Upsized Pricing of $110,000,000 Initial Public Offering
-
Form DEFA14A Chardan Healthcare Acqui
-
Chardan Healthcare Acquisition 2 Corp. Announces Renovacor's Appointment of Matt Killeen, Ph.D., as Chief Scientific Officer
-
Form DEFA14A Chardan Healthcare Acqui
-
Renovacor Announces the Appointment of Matt Killeen, Ph.D., as Chief Scientific Officer
-
UPDATE: Chardan Capital Markets Starts Tenaya Therapeutics Inc (TNYA) at Buy
-
Abri SPAC I, Inc. Announces Closing of Over-Allotment Option in Connection With Its Initial Public Offering
-
Chardan NexTech Acquisition 2 Corp. Announces the Separate Trading of its Common Stock and Warrants, Commencing August 24, 2021
-
Form 8-K Chardan NexTech Acquisit For: Aug 23
-
Sonnet BioTherapeutics (SONN) Prices 35.3M Share+Warrant Offering at $0.85/sh
-
Sonnet BioTherapeutics Announces Pricing of $30 Million Underwritten Public Offering
-
Form 8-K Chardan NexTech Acquisit For: Aug 13
-
Form DEFA14A Chardan Healthcare Acqui
-
Chardan NexTech Acquisition 2 Corp. Announces Closing of Underwriters' Over-Allotment Option to Purchase Additional Units in Connection with its Initial Public Offering
-
Form SC 13G Chardan NexTech Acquisit Filed by: MMCAP International Inc. SPC
-
Form 10-Q Chardan Healthcare Acqui For: Jun 30
-
Form NT 10-Q Chardan Healthcare Acqui For: Jun 30
-
AgeX Therapeutics Reports Second Quarter 2021 Financial Results
-
Form 8-K Chardan NexTech Acquisit For: Aug 10
-
Chardan NexTech Acquisition 2 Corp. Announces Closing of Upsized $110 Million Initial Public Offering
-
Abri SPAC I, Inc. Announces Closing of $50 Million Initial Public Offering
-
Form 424B4 Chardan NexTech Acquisit
-
Homology Medicines Reports Second Quarter 2021 Financial Results and Recent Highlights
-
International Media Acquisition Corp. Announces the Separate Trading of its Common Stock, Rights and Warrants, Commencing August 17, 2021
-
Form 3 Chardan NexTech Acquisit For: Aug 10 Filed by: Chardan NexTech Investments 2 LLC
-
Form 3 Chardan NexTech Acquisit For: Aug 10 Filed by: PROPPER KERRY
-
Form EFFECT Chardan NexTech Acquisit

